RE:RE:0.27 If they can just get one or two good deals by end of May/summer, I think the tables could turn for good. My bets are with Top10 and Animal Health but there is an interesting piece on Anti-aging we can not forget. As well, Anti-viral too.
We heard what PRC thinks of the first one, but there seems to be some new clues in the most recent February presentation on this second item that nobody is talking about. That seems to have experienced some important course correction recently.
I keep saying if they can get just one important deal done, the second and maybe third etc, will come a heck of a lot easier.
Anyhow, didn't come this far to throw the towel in, things are "looking" much better than 2021.